NESS ZIONA, Israel, March 30, 2017 /PRNewswire CollPlant (TASE: CLPT), a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue repair products (recombinant human, “rhCollagen”), today provided a commercial and operational update in its annual reports. Most recently, in November 2016, the Company announced the signing of an […]